Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones

Launched by AIR FORCE MILITARY MEDICAL UNIVERSITY, CHINA · Sep 14, 2023

Keywords

ClinConnect Summary

This clinical trial is studying patients who have both intrahepatic bile duct stones (stones inside the liver) and extrahepatic bile duct stones (stones outside the liver). The goal is to understand how effective a procedure called endoscopic retrograde cholangiopancreatography (ERCP) is in treating these stones and to find out if patients are likely to experience recurring stones in the future. Researchers want to identify any factors that might increase the chances of having more stones after treatment.

To participate in this study, patients must have had ERCP treatment for their bile duct stones at Xijing Hospital in China between July 2008 and December 2020. The trial is open to all adults who meet these criteria, but patients with certain other conditions, like strictures or liver diseases, cannot participate. If you join the study, you can expect to contribute to important research that may help improve future treatments for people with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • non-gastrointestinal tract reconstruction patients with coexisting IBD and EBD stones who underwent ERCP between July 2008 and December 2020 at Xijing Hospital in China
• Exclusion Criteria:
• • patients with benign or malignant EBD strictures
• • sclerosing cholangitis
• • suspected choledochal cysts
• • liver cirrhosis
• • parasitic liver diseases
• • long-term biliary drainage with biliary stents or percutaneous tubes
• • without a definitive IBD stone or with a diagnosis of liver calcification as determined by imaging review
• • medical records or follow-up information was unavailable